Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Intelligent Bio Solutions Inc. - Common Stock (NQ: INBS )

2.310 -0.160 (-6.48%)
Streaming Delayed Price Updated: 12:59 PM EDT, May 10, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 84,230
Open 2.550
Bid (Size) 2.310 (1)
Ask (Size) 2.350 (2)
Prev. Close 2.470
Today's Range 2.300 - 2.550
52wk Range 0.1900 - 11.70
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
INBS Stock Earnings: Intelligent Bio Solutions Beats EPS, Misses Revenue for Q3 2024
INBS stock results show that Intelligent Bio Solutions beat analyst estimates for earnings per share but missed on revenue for the third quarter of 2024. 
Via InvestorPlace
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire

Performance

YTD
+600.42%
+600.42%
1 Month
-36.19%
-36.19%
3 Month
-19.79%
-19.79%
6 Month
+428.60%
+428.60%
1 Year
-21.96%
-21.96%

More News

Read More
Discovering Undervalued Stocks in Today’s Market: OCGN, INBS, KAVL, DYAI, VTAK
Via AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
Via Talk Markets
Exploring Emerging Companies with Key Developments Garnering Attention: INBS, INVO, VTAK, RCAT, GCTK
Via AB Newswire
Looking Into Intelligent Bio Solutions's Recent Short Interest
Via Benzinga
Peering Into Intelligent Bio Solutions's Recent Short Interest
Via Benzinga
Peering Into Intelligent Bio Solutions's Recent Short Interest
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Intelligent Bio Solutions Inc. (NASDAQ: INBS): Pioneering Advances in Medical Technology – Full Analysis Inside!
Via AB Newswire
Exposures Product Safety
Key Stocks to Watch: Recent News, Developments and Market Potential KAVL, INBS, GEVI, VTAK, RLYB
Via AB Newswire
Topics Intellectual Property
Exposures Intellectual Property
Stocks to Watch for Short Squeeze Potential: DJT, INBS, IMPP, HUBC, XXII
Via AB Newswire
Topics Government
Exposures Political
Ladenburg Thalmann, Esteemed Wall Street Long-Standing Stalwart Since 1876, Advocates ‘Buy’ for Intelligent Bio, Precision Bio, and More: VTAK, INBS, LASE, MYMD, RVSN
Via AB Newswire
Reddit Inc. (NYSE: RDDT) Surges, Uncovering Undervalued Opportunities: DYAI, INBS, MESO, VTAK
Via AB Newswire
Topics Initial Public Offering
Exposures Product Safety Securities Market
March Madness 2024: Key Players in Medical Tech, Healthcare and AI: INBS, AMTX, VTAK, ANGH, TRUG
Via AB Newswire
Topics Energy
Exposures Fossil Fuels
March Madness Market Movers: INBS, NCMI, CIFR, IMRX, STI
Via AB Newswire
Emerging Companies: Key Developments and Investment Insights RGLS, INBS, VTAK, DYAI, TCBP
Via AB Newswire
Intelligent Bio Solutions Inc. (NASDAQ: INBS) Closes $10M Private Offering Amid Investor Interest
Via AB Newswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Market Momentum: Analyzing Five Stocks Exhibiting Strong Upward Trends: INBS, MEDS, IFBD, AISP, VTAK
Via AB Newswire
Intelligent Bio Solutions Inc (NASDAQ: INBS) Teams Up with Cliantha Research for FDA 510(k) Pathway Clinical Study
Via AB Newswire
Exposures Product Safety
Exploring Stocks with High Short Interest: INBS, BLNK, BYND, NVAX, PLUG
Via AB Newswire
Topics Electric Vehicles
Exposures COVID-19 Electric Vehicles
Healthcare Undervalued Opportunities Poised for Growth: DYAI, INBS, VTAK, RSCI, VERO, MRVI
Via AB Newswire
Breaking Ground in BioPharma: Spotlight Companies DYAI, INBS, SANA, IOVA, BLUE
Via AB Newswire
Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.